Community Research and Development Information Service - CORDIS

Development of pregnenolone derivatives as allosteric inhibitors of CB1 cannabinoid receptors for thetreatment of schizophrenia and psychotic syndromes

From 2015-01-01 to 2016-06-30, closed project

Project details

Total cost:

EUR 150 000

EU contribution:

EUR 150 000

Coordinated in:

France

Call for proposal:

ERC-2014-PoCSee other projects for this call

Funding scheme:

ERC-POC - Proof of Concept Grant

Objective

Host Institution

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
France

EU contribution: EUR 150 000


RUE DE TOLBIAC 101
75654 PARIS
France
Activity type: Research Organisations

Beneficiaries

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
France

EU contribution: EUR 150 000


RUE DE TOLBIAC 101
75654 PARIS
France
Activity type: Research Organisations

To know more

Record Number: 193761 / Last updated on: 2017-02-14